[ScinoPharm] Announcement regarding the Board's approval to lift non-compete restrictions for managers

ScinoPharm has approved the lifting of non-compete restrictions for Chairman Luo Chih-hsien and General Manager Lu Li-an, allowing them to hold concurrent positions within the Uni-President Group's China operations. There is no financial impact on ScinoPharm.
businessNQ 44/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 27, 2026 at 09:00
  • 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 31, 2026 at 18:51 (82h 51m after Collected)
1. Date of Board resolution: 2026/05/27
2. Name and title of managers permitted to engage in competitive activities: Luo Chih-hsien (Chairman and Chief Strategy Officer), Lu Li-an (General Manager)
3. Items permitted: Concurrent management of other profit-seeking enterprises and operating similar businesses for self or others
4. Duration: During the tenure as a manager of the Company
5. Resolution status: Approved unanimously by all attending directors
6. Managers involved in mainland China business: Luo Chih-hsien
7. Company names and positions held in mainland China: Chairman of Zhangjiagang Uni-President Food Co., Ltd., Chairman of Uni-President (China) Investment Co., Ltd., Director of Huangming Enterprise Management Consulting (Shanghai) Co., Ltd., and various other Uni-President subsidiaries.
8. Addresses of mainland China businesses: Various locations across China.
9. Business scope of mainland China entities: Manufacturing and sales of instant noodles, beverages, dairy products, meat products, mineral water, refined oils, processed oils, soy sauce, and seasonings.
10. Impact on the Company's financial and business operations: None
11. Investment amount and shareholding ratio of managers in said mainland China businesses: None
12. Other matters: None

FAQ

Why is this disclosure required?

Under Taiwan's Company Act, directors and managers must obtain board approval and disclose any concurrent positions in competing businesses to protect shareholder interests.